107 related articles for article (PubMed ID: 26430739)
1. MicroRNA Expression in Myocardial Tissue and Plasma of Patients with End-Stage Heart Failure during LVAD Support: Comparison of Continuous and Pulsatile Devices.
Lok SI; de Jonge N; van Kuik J; van Geffen AJ; Huibers MM; van der Weide P; Siera E; Winkens B; Doevendans PA; de Weger RA; da Costa Martins PA
PLoS One; 2015; 10(10):e0136404. PubMed ID: 26430739
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device.
Morley-Smith AC; Mills A; Jacobs S; Meyns B; Rega F; Simon AR; Pepper JR; Lyon AR; Thum T
Eur J Heart Fail; 2014 Aug; 16(8):871-9. PubMed ID: 24961598
[TBL] [Abstract][Full Text] [Related]
3. Left ventricular assist device effects on metabolic substrates in the failing heart.
Weitzel LB; Ambardekar AV; Brieke A; Cleveland JC; Serkova NJ; Wischmeyer PE; Lowes BD
PLoS One; 2013; 8(4):e60292. PubMed ID: 23560088
[TBL] [Abstract][Full Text] [Related]
4. Computational evaluation of heart failure and continuous flow left ventricular assist device support in anaemia.
Bozkurt S
Int J Numer Method Biomed Eng; 2024 Jan; 40(1):e3781. PubMed ID: 37814938
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of continuous and pulsatile left ventricular-assist devices on ventricular unloading using a cardiac electromechanics model.
Lim KM; Constantino J; Gurev V; Zhu R; Shim EB; Trayanova NA
J Physiol Sci; 2012 Jan; 62(1):11-9. PubMed ID: 22076841
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Indices for Non-invasive Myocardial Recovery Assessment in LVAD-Supported Heart Failure Patients.
Boss LA; Lovell NH; Stevens MC
Annu Int Conf IEEE Eng Med Biol Soc; 2023 Jul; 2023():1-4. PubMed ID: 38082936
[TBL] [Abstract][Full Text] [Related]
7. Echocardiographic imaging and ventricular mechanics in pulsatile-flow LVAD pediatric patients: a systematic approach.
Iacobelli R; Di Molfetta A; Amodeo A
Front Pediatr; 2024; 12():1345891. PubMed ID: 38348212
[TBL] [Abstract][Full Text] [Related]
8. Amiodarone Prophylaxis Is Reasonably Safe and Potentially Beneficial After CF-LVAD.
Graboyes SDT; Hollis IB
ASAIO J; 2023 Sep; 69(9):e421-e422. PubMed ID: 37651098
[No Abstract] [Full Text] [Related]
9. Circulating microRNAs as Biomarkers in Cardiovascular Diseases.
De Rosa S; Indolfi C
Exp Suppl; 2015; 106():139-149. PubMed ID: 26608202
[TBL] [Abstract][Full Text] [Related]
10. Circulating microRNAs and Outcome in Patients with Acute Heart Failure.
Seronde MF; Vausort M; Gayat E; Goretti E; Ng LL; Squire IB; Vodovar N; Sadoune M; Samuel JL; Thum T; Solal AC; Laribi S; Plaisance P; Wagner DR; Mebazaa A; Devaux Y;
PLoS One; 2015; 10(11):e0142237. PubMed ID: 26580972
[TBL] [Abstract][Full Text] [Related]
11. Circulating microribonucleic acids miR-1, miR-21 and miR-208a in patients with symptomatic heart failure: Preliminary results.
Sygitowicz G; Tomaniak M; Błaszczyk O; Kołtowski Ł; Filipiak KJ; Sitkiewicz D
Arch Cardiovasc Dis; 2015 Dec; 108(12):634-42. PubMed ID: 26498537
[TBL] [Abstract][Full Text] [Related]
12. Thromboembolic stroke in patients with a HeartMate-II left ventricular assist device - the role of anticoagulation.
van den Bergh WM; Lansink-Hartgring AO; van Duijn AL; Engström AE; Lahpor JR; Slooter AJ
J Cardiothorac Surg; 2015 Oct; 10():128. PubMed ID: 26471178
[TBL] [Abstract][Full Text] [Related]
13. The contemporary role of Impella in a comprehensive mechanical circulatory support program: a single institutional experience.
Pieri M; Contri R; Winterton D; Montorfano M; Colombo A; Zangrillo A; De Bonis M; Pappalardo F
BMC Cardiovasc Disord; 2015 Oct; 15():126. PubMed ID: 26466899
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary Bleeding During Right Ventricular Support After Left Ventricular Assist Device Implantation.
Welp H; Sindermann JR; Deschka H; Martens S; Scherer M
J Cardiothorac Vasc Anesth; 2016 Jun; 30(3):627-31. PubMed ID: 26460277
[TBL] [Abstract][Full Text] [Related]
15. Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock.
Gaudard P; Mourad M; Eliet J; Zeroual N; Culas G; Rouvière P; Albat B; Colson P
Crit Care; 2015 Oct; 19():363. PubMed ID: 26453047
[TBL] [Abstract][Full Text] [Related]
16. Structural heart interventions training in Europe.
Marmagkiolis K; Arzamendi D; Goktekin O; Cilingiroglu M
Int J Cardiol; 2016 Jan; 202():532-4. PubMed ID: 26443939
[TBL] [Abstract][Full Text] [Related]
17. Use of Extracorporeal Membrane Oxygenation in Refractory Cardiogenic Shock.
Tariq S; Gass A
Cardiol Rev; 2016; 24(1):26-9. PubMed ID: 26440651
[TBL] [Abstract][Full Text] [Related]
18. The increasing importance of percutaneous mechanical circulatory assist device therapy in heart failure management.
Weis RA; Devaleria PA; Koushik S; Ramakrishna H
Ann Card Anaesth; 2015; 18(4):467-73. PubMed ID: 26440230
[TBL] [Abstract][Full Text] [Related]
19. Promotion of progressive mobility activities with ventricular assist and extracorporeal membrane oxygenation devices in a cardiothoracic intensive care unit.
Chavez J; Bortolotto SJ; Paulson M; Huntley N; Sullivan B; Babu A
Dimens Crit Care Nurs; 2015; 34(6):348-55. PubMed ID: 26436301
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous SAPIEN S3 Transcatheter Valve Implantation for Post-Left Ventricular Assist Device Aortic Regurgitation.
Kornberger A; Beiras-Fernandez A; Fichtlscherer S; Assmus B; Moritz A; Stock UA
Ann Thorac Surg; 2015 Oct; 100(4):e67-9. PubMed ID: 26434481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
